I'm all for the potential of Pointerra, but revenues of ~3.1m &...

I'm all for the potential of Pointerra, but revenues of ~3.1m & cash receipts of ~3.5m for 1H22 (so lets say both annualising at ~7m) with a MC of ~180m is hardly cheap.

Yes I know ACV is double that 7m etc etc, but end of the day, all companies have to be valued on some fundamentals....and possibly the reason that the share price is depressed is that cashflow is 4-6 quarters behind ACV. What has also started to happen is that the company has started to have net cash outflows (albeit small), but with only ~5m in the bank, you don't have a lot of room to burn cash (even if it is for growth).

Anyway, material contracts may just be around the corner (but they always have been), but the delays in bringing that cash in is what is hurting the price IMO